CorVel Co. (NASDAQ:CRVL – Get Free Report) Director Jeffrey J. Michael sold 10,477 shares of the business’s stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $116.45, for a total value of $1,220,046.65. Following the sale, the director now owns 568,310 shares in the company, valued at approximately $66,179,699.50. The trade was a 1.81 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
CorVel Stock Down 2.1 %
Shares of NASDAQ:CRVL opened at $103.89 on Thursday. The company has a market cap of $5.34 billion, a P/E ratio of 61.11 and a beta of 1.06. The company’s fifty day moving average is $112.40 and its two-hundred day moving average is $114.13. CorVel Co. has a 12-month low of $76.20 and a 12-month high of $128.61.
CorVel (NASDAQ:CRVL – Get Free Report) last posted its quarterly earnings results on Tuesday, February 4th. The business services provider reported $0.46 earnings per share for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.
Institutional Trading of CorVel
Wall Street Analyst Weigh In
Separately, StockNews.com upgraded shares of CorVel from a “hold” rating to a “buy” rating in a report on Wednesday, February 26th.
Read Our Latest Analysis on CorVel
CorVel Company Profile
CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
Further Reading
- Five stocks we like better than CorVel
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- How to invest in marijuana stocks in 7 steps
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.